Department of Intensive Care, Erasmus Medical Center, Rotterdam, the Netherlands.
Department of Intensive Care, Radboud UMC Nijmegen, Nijmegen, the Netherlands.
Crit Care Explor. 2024 Aug 20;6(8):e1132. doi: 10.1097/CCE.0000000000001132. eCollection 2024 Aug.
This study aimed to assess the impact of race on pulse oximetry reliability, taking into account Spo ranges, COVID-19 diagnosis, and ICU admission.
Retrospective cohort study covering admissions from January 2020 to April 2024.
National COVID Cohort Collaborative (N3C) database, consisting of electronic health records from 80 U.S. institutions.
PATIENTS/SUBJECTS: Patients were selected from the N3C database based on the availability of data on self-identified race and both pulse oximetry estimated Spo and Sao. Subgroups included patients in ICU and non-ICU settings, with or without a diagnosis of COVID-19 disease.
None.
The agreement between Spo and Sao was assessed across racial groups (American Indian or Alaska Native, Asian, Black, Hispanic or Latino, Pacific Islander, and White). Each patient's initial Sao measurement was matched with the closest Spo values recorded within the preceding 10-minute time frame. The risk of hidden hypoxemia (Spo ≥ 88% but Sao < 88%) was determined for various Spo ranges, races, and clinical scenarios. We used a generalized logistic mixed-effects model to evaluate the impact of relevant variables, such as COVID-19, ICU admission, age, sex, race, and Spo, on the risk of hidden hypoxemia, while accounting for the random effects within each hospital. A total of 80,541 patients were included, consisting of 596 American Indian or Alaska Native, 2,729 Asian, 11,889 Black, 13,154 Hispanic or Latino, 221 Pacific Islander, and 51,952 White individuals. Discrepancies between Spo and Sao were observed across all racial groups, with the most pronounced bias in Black patients. Hidden hypoxemia rates were higher in Black patients across all Spo subgroups, for all clinical scenarios. The odds of hidden hypoxemia were higher for Black and Hispanic or Latino patients and for those with COVID-19 disease.
Race significantly impacts pulse oximetry reliability. Not only Black and Hispanic or Latino patients were at higher risk for hidden hypoxemia, but also those admitted with a COVID-19 diagnosis. Future in-depth explorations into the underlying causes and potential solutions are needed.
本研究旨在评估种族对脉搏血氧饱和度仪可靠性的影响,同时考虑 SpO2 范围、COVID-19 诊断和 ICU 收治情况。
回顾性队列研究,涵盖 2020 年 1 月至 2024 年 4 月的入院患者。
N3C 数据库,包含 80 家美国机构的电子健康记录。
患者/受试者:根据是否存在自我报告的种族、脉搏血氧饱和度仪估计的 SpO2 和 Sao 数据,从 N3C 数据库中选择患者。亚组包括 ICU 和非 ICU 环境下的患者,以及患有或未患有 COVID-19 疾病的患者。
无。
评估了不同种族(美洲印第安人或阿拉斯加原住民、亚洲人、黑人、西班牙裔或拉丁裔、太平洋岛民和白人)的 SpO2 和 Sao 之间的一致性。每位患者的初始 Sao 测量值与之前 10 分钟内记录的最接近的 SpO2 值相匹配。确定了不同 SpO2 范围、种族和临床情况下的隐匿性低氧血症(Spo≥88%但 Sao<88%)的风险。我们使用广义逻辑混合效应模型评估了 COVID-19、ICU 收治、年龄、性别、种族和 SpO2 等相关变量对隐匿性低氧血症风险的影响,同时考虑了每个医院内的随机效应。共纳入 80541 例患者,包括 596 名美洲印第安人或阿拉斯加原住民、2729 名亚洲人、11889 名黑人、13154 名西班牙裔或拉丁裔、221 名太平洋岛民和 51952 名白人。所有种族群体的 SpO2 和 Sao 之间都存在差异,其中黑人患者的偏差最明显。在所有 SpO2 亚组中,黑人患者的隐匿性低氧血症发生率均较高,所有临床情况下均如此。黑人患者和西班牙裔或拉丁裔患者以及 COVID-19 患者隐匿性低氧血症的可能性更高。
种族对脉搏血氧饱和度仪的可靠性有显著影响。不仅黑人患者和西班牙裔或拉丁裔患者隐匿性低氧血症的风险更高,而且 COVID-19 患者也存在这种风险。需要进一步深入研究潜在原因和潜在解决方案。